characteristics.text: SAMN50428115
characteristics.characteristic: External Id
characteristics.text: Bound Therapeutics
characteristics.characteristic: INSDC center name
characteristics.text: 2025-08-02T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2025-08-02T15:01:03.960Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS26057484
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Human
characteristics.characteristic: NCBI submission model
characteristics.text: Human.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS26057484
characteristics.characteristic: SRA accession
characteristics.text: 60
characteristics.characteristic: age
characteristics.text: Dr. Eric Wickstrom
characteristics.characteristic: biomaterial_provider
characteristics.text: 2021-01-21
characteristics.characteristic: collection_date
characteristics.text: USA:Pennsylvania
characteristics.characteristic: geo_loc_name
characteristics.text: The HCC1806 breast cancer cell line was initiated on July 31, 1995, and took 10 months to establish.
characteristics.characteristic: isolate
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: female
characteristics.characteristic: sex
characteristics.text: breast
characteristics.characteristic: tissue
characteristics.text: Human sample from Homo sapiens
characteristics.characteristic: title